About Curatis AG

Founded in 2002 by experienced industry executives, Curatis is a privately owned speciality pharmaceutical company engaged in two business areas:

Distribution business

Curatis acquires, licences, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and speciality diseases in Switzerland.

Development business

Curatis has a promising pipeline of novel speciality care and orphan drugs for neurological disorders based on the principle of repurposing.